CUV 1.42% $13.90 clinuvel pharmaceuticals limited

Aussie biotech takeover offer

  1. 4,698 Posts.
    lightbulb Created with Sketch. 72
    Sector may hot up, Aussie biotech Clinuvel CUV in an unsolicited takeover situation by a Retrophin RTRX a Nasdaq listed company. Look out the yanks want our shares
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.